Cell and Gene Therapy, Industry
March 25, 2021
Via: BioSpaceOn the back of a $135 million public offering in February, rare disease gene therapy company Krystal Biotech has launched subsidiary Jeune Inc. to promote its gene therapies for aesthetic skin conditions. In conjunction with the launch, Jeune announced positive […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 20, 2023
September 1, 2023
September 14, 2023
August 30, 2023